nivolumab
bms
['biomarker', 'melanoma', 'nivo']
after tmb and ifng signature the third most predictive biomarker for nivo monotherapy in resected stage ii melanoma .sex presented by #asco23 
Melanoma and high risk skin cancer medical oncologist. Studying hereditary and somatic genomics. CA explant in OH. (IO!) Sports fan, geek, and mommy. Tweets=me.